- freely available
Nutrients 2011, 3(1), 152-163; doi:10.3390/nu3010152
Abstract: Serum fatty acids are increasingly used in cross-sectional surveys and cohort studies as biomarkers of dietary fat intake; however, it is currently difficult to judge whether an individual has low or high fatty acid status, or whether the distribution of fatty acids of a group of people is low or high due to a lack of appropriate reference values. In the absence of interpretive criteria, the distribution of serum fatty acids from a suitable reference population can be used as an alternative. We describe the distribution of the fatty acid composition of the three most commonly reported lipid classes in serum; cholesterol ester, phospholipid and triacylgycerol. Results for each serum lipid class are presented as means (SD) and percentiles (5, 10, 25, 50, 75, 90, and 95) of serum fatty acids in non-fasting blood samples collected from a population based cross-sectional survey of New Zealand adults (n = 2793). These serum fatty acid reference ranges are applicable and relevant to Australia, United Kingdom, and United States as well as other countries where fat intakes are similar to New Zealand.
The nutritional status of populations is normally assessed using a range of dietary, anthropometric and biochemical measurements. Interpretive criteria for these measures are used to judge the adequacy of nutritional status. Cutpoints or reference values which define the stages of deficiency, insufficiency, adequacy, or excess are the most common interpretive criteria. However, when scientific evidence is insufficient to establish cutpoints for a particular measurement, the distribution range of the measurement in the population can be used to judge if status is high or low for individuals or groups.
A number of serum fatty acids are valid biomarkers of dietary fat intake, and their measurement is becoming a complementary tool in nutrition surveys to monitor the types of fats consumed and in prospective studies designed to generate knowledge about the relation between various types of dietary fat and disease risk . Unfortunately, there is little in the way of interpretive criteria or distribution reference ranges to judge serum fatty acid status of the individual. In general, serum fatty acid composition, given as the molecular percentage of total fatty acids (mol%), or as a weight percent, tends to be reported as mean and standard deviation. We have previously reviewed and summarised this literature ; however, virtually all of the results came from studies in which the participants were not randomly selected from the population, thus, there is a need for data which can be generalised to national populations.
The usefulness of representative population-based serum fatty acid data reported as percentiles is obvious because it will enable researchers and epidemiologists to evaluate and judge what constitutes high or low fatty acid status. For example, what constitutes a high or low value for serum linoleic acid, the predominant polyunsaturated serum fatty acid, or serum myristic acid, a marker of dairy fat intake in a reference population?
In this paper we report the percentiles of serum phospholipid, cholesterol ester, and triacylglycerol fatty acids from a nation-wide representative survey of New Zealand adults.
2.1. Survey Methods
All participants in the New Zealand 1997 National Nutrition survey (NNS97) were recruited from the 1996/1997 New Zealand Health Study (NZHS). Ethical approval for the surveys was obtained from the 14 ethics committees throughout New Zealand, and all participants (or the guardians of those less than 18 years old) gave informed written consent. The methodology for both surveys has been described in detail elsewhere [2,3,4]. Briefly, a three stage stratified design was used in the 1996/1997 NZHS. New Zealand was divided into 18,880 small geographical areas. These primary sampling units (PSU) were divided into 122 strata, based on various geographical and socioeconomic characteristics. The first stage of the survey involved selection of PSUs. Secondly, households within the PSUs were randomly chosen. Finally, one eligible adult from the chosen household was randomly selected to participate in the NZHS. All participants who consented to participate in the 1996/1997 NZHS were invited to participate in the NNS97 which was to follow several months later than the NZHS. Those who consented to participate in NNS97 were interviewed in their homes. During the home-interview, height and weight were measured, and body mass index (BMI, kg/m2) calculated. Smoking status and ethnicity were self-reported. Also during this interview, NNS97 participants completed a computer‑assisted 24 h dietary recall, and were asked to provide a blood sample. The NNS97 participants were not asked to fast before the blood sample was collected. Blood was taken into a 10 mL vacuum evacuated tube with no anticoagulant and tubes immediately placed in a polystyrene container which contained an ice pack. The container was sent on the same day to a laboratory for processing and storage of serum. Serum was stored at −80 °C until the fatty acid analysis.
2.2. Serum Fatty Acid Analysis
Serum lipids were extracted according to the method of Bligh and Dyer . To separate out lipid classes, the lipid extracts were spotted onto silica gel coated thin layer chromatography plates and placed in a glass tank containing a solvent system of hexane:diethyl ether:acetic acid, in the ratio 85:15:1 by volume. The lipid bands were visualised by spraying the glass plates with 0.1% solution (weight:volume) of 8-anilino-1-napthalene sulfonic acid and viewing them under ultraviolet light. Serum cholesterol ester, phospholipid and triacylglycerol bands were scraped into glass test tubes and the fatty acids were converted into fatty acid methyl esters using 6% sulphuric acid in methanol and incubating at 80 °C for 2 h, for cholesterol ester and triacylglycerol, and 12–16 h, for phospholipid. The samples were then eluted into hexane and stored at −20 °C.
An HP6890 Series Gas Chromatograph (Aligent, Palo Alto, CA) with a DB-225 megabore column (internal diameter: 30 m × 0.25 mm; film thickness: 0.25 µm; J & W Scientific, Deerfield, IL) and flame ionization detection was used to separate fatty acids. Blank extractions were analysed to correct for background contamination. Throughout the analysis, precision was monitored by analysing one pooled serum sample for every 20 NNS97 samples. The coefficients of variation (CVs) for the fatty acid analysis were below 15% for the vast majority of fatty acids in serum cholesterol ester, phospholipid and triacylglycerol (Table 1). The fatty acids are reported as molecular percents (mol%).
2.3. Statistial Analysis
STATA (version 9.0; Stata Corp, College Station, TX) was used for all statistical analyses. Differences in the distribution of variables between the NNS97 participants who had a fatty acid measurement of at least one of serum cholesterol ester, phospholipid, or triacylglycerol, and NNS97 participants who did not have a fatty acid measurement, were tested using t-tests for continuous variables and chi-squared tests for categorical variables. The major fatty acids—for which greater than 75% of the study population had a detectable value—in serum cholesterol ester, phospholipid and triacylglycerol are presented. For the serum fatty acid analyses, survey commands were used to take into account the complex survey design of the NNS97. The survey-adjusted mean (SD) as well as percentiles were calculated for each of the major fatty acids.
|Fatty acid||Cholesterol ester||Phospholipid||Triacylgycerol|
SAFA: saturated; MUFA: monounsaturated; PUFA: polyunsaturated.
3. Results and Discussion
In total, 7862 people—a response rate of 73.8%—participated in the NZHS. Of these participants, 4636 completed a 24 h recall for the NNS97, and 69.5% of the NNS97 participants (n = 3228) consented to blood samples. The fatty acid composition of serum cholesterol ester, phospholipid and triacylglycerol was analysed for 2393, 2416, and 2402 participants, respectively. The fatty acid composition of at least one of the serum lipid classes was obtained from 2793 participants.
Participant characteristics are presented in Table 2. It has previously been reported that the 1996/1997 sample (n = 7862) was similar to the NNS97 sample (n = 4636) with respect to the distribution of sex, age, ethnicity, marital status, labourforce status and smoking status . The P values presented in Table 2 are from tests comparing the characteristics of the NNS97 participants who had the fatty acid composition of at least one of serum cholesterol ester, phospholipid, or triacylglycerol measured, and the NNS97 participants that did not have any serum fatty acid measurement. There were small but statistically significant differences in the distribution of sex, age, ethnicity, and BMI between NNS97 participants who had a fatty acid measurement and NNS97 participants who did not. There were no significant differences in smoking status, serum cholesterol concentrations, or in the intakes of dietary fat between these two groups. Most of the participants were between the ages of 25 to 44 years. Approximately one third of the participants were overweight, with an additional fifth classified as obese. Just over a quarter of the participants were current smokers. Sixteen percent of participants reported consuming fish in the previous 24 h. Dairy fat accounted for 20% of the total dietary fat (data not shown). Fat intakes and major food sources of fat did not differ between participants who had a fatty acid value and participants who did not (Table 2).
|1996/1997 NZHS||NNS97 participants||Fatty acid measurement 1||No fatty acid measurement||P 2|
|n (%) of 1996/1997 NZHS||7862 (100.0)||4636 (59.0)||2793 (35.5)||1843 (23.4)|
|Females||4604 (58.6)||2709 (58.4)||1547 (55.4)||1162 (63.0)||<0.001|
|Age category (y)|
|15 to 18||405 (5.2)||246 (5.3)||122 (4.4)||124 (6.7)||0.001|
|19 to 24||645 (8.2)||354 (7.6)||210 (7.5)||144 (7.8)|
|25 to 44||3221 (41.0)||1964 (42.4)||1227 (43.9)||737 (40.0)|
|45 to 64||2063 (26.2)||1255 (27.1)||765 (27.4)||490 (26.6)|
|65+||1528 (19.4)||817 (17.6)||469 (16.8)||348 (18.9)|
|NZEO||5896 (75.0)||3626 (78.2)||2286 (81.8)||1340 (72.7)||<0.001|
|NZ Maori||1321 (16.8)||703 (15.2)||368 (13.2)||335 (18.2)|
|Pacific people||646 (8.2)||307 (6.6)||139 (5.0)||168 (9.1)|
|Normal||-||1882 (40.6)||1189 (42.6)||693 (37.6)||<0.001|
|Overweight||-||1530 (33.0)||999 (35.8)||531 (28.8)|
|Obese||-||967 (20.9)||551 (19.7)||416 (22.6)|
|Not measured||-||257 (5.5)||54 (1.9)||203 (11.0)|
|Current smokers||2280 (29.0)||1258 (27.1)||763 (27.3)||495 (26.9)||0.730|
|Total cholesterol (mmol/L) 3||-||5.8 (1.2)||5.8 (1.2)||5.8 (1.2)||0.6876|
|HDL cholesterol (mmol/L) 3||-||1.3 (0.4)||1.3 (0.4)||1.3 (0.4)||0.5642|
|Dietary fat intake (% of kJ) 3|
|Total fat||-||34.27 (11.90)||34.41 (8.74)||34.32 (9.12)||0.7416|
|Saturated fat||-||14.68 (5.10)||14.72 (5.01)||14.61 (5.22)||0.4845|
|Dairy fat||-||7.38 (6.87)||7.49 (6.88)||7.23 (6.84)||0.2173|
|Monounsaturated fat||-||11.37 (3.62)||11.38 (3.55)||11.37 (3.71)||0.9575|
|Polyunsaturated fat||-||4.85 (2.49)||4.83 (2.47)||4.87 (2.52)||0.6573|
|Fish fat||-||0.62 (2.45)||0.61 (2.33)||0.64 (2.63)||0.6582|
NZHS, New Zealand Health Survey; NNS97, New Zealand National Nutrition Survey; CE, cholesterol ester; PL, phospholipid; TAG, triacylglycerol; NZEO, New Zealand European or other; NZ, New Zealand; 1 NNS97 participants who had the fatty acid composition of at least one of serum cholesterol ester, phospholipid or triacylglycerol measured; 2 For the difference between NNS97 participants who had a fatty acid value (n = 2793) and those who did not (n = 1843). Differences were tested using chi-squared tests for categorical variables and t-tests for continuous variables; Values are number (%) unless otherwise indicated; 3 Mean (SD).
Table 3, Table 4 and Table 5 report the fatty acid composition of serum cholesterol ester, phospholipid and triacylglycerol as means (SD) and percentiles. We describe the following fatty acid results: myristic acid (14:0) and pentadecanoic acid (15:0) as they are good biomarkers of dairy and saturated fat intake; linoleic acid (18:2n-6) as it is the major polyunsaturated fatty acid in the diet and in serum; and the major long chain n-3 polyunsaturated fatty acids, eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3).
The proportion of myristic acid was highest in serum triacylglycerol followed by serum cholesterol ester and phospholipid. The median (10th and 90th percentile) of myristic acid in serum triacylglycerol was 3.36 mol% (1.83 and 5.67 mol%), 1.01 mol% (0.61 and 1.57 mol%) in cholesterol ester, and 0.50 mol% (0.33 and 0.72 mol%) in phospholipid.
Pentadecanoic acid was present in smaller amounts than myristic acid in all three lipid classes. The median (10th and 90th percentile) of pentadecanoic acid was highest in serum triacylglycerol at 0.51 mol% (0.33 and 0.80 mol%) and similar in phospholipid and cholesterol ester at 0.29 (0.20 and 0.39 mol%) and 0.28 mol% (0.19 and 0.40 mol%), respectively.
Linoleic acid was the major fatty acid in serum cholesterol ester, and the major polyunsaturated fatty acid in phospholipid and triacylglycerol. The median contribution (10th and 90th percentile) was 50.30 mol% (41.02 and 57.42 mol%) in cholesterol ester, 19.25 mol% (14.56 and 23.31 mol%) in phospholipid, and 13.38 mol% (8.18 and 21.08 mol%) in triacylglycerol.
The percentiles of eicosapentaenoic acid in serum cholesterol ester and phospholipid were similar with a median (10th and 90th percentile) value of 0.96 mol% (0.50 and 1.66 mol%) in cholesterol ester and 0.92 mol% (0.51 and 1.53 mol%) in phospholipid. The proportion of eicosapentaenoic acid in triacylglycerol was lower; the median contribution (10th and 90th percentile) was 0.23 mol% (0.12 and 0.42 mol%).
The median contribution of docosahexaenoic acid was highest in serum phospholipid at 2.55 mol% and similar in cholesterol ester (0.48 mol%) and triacylglycerol (0.42 mol%). For the central 80% (10th to 90th percentile) of the participants, docosahexaenoic acid contributed between 1.63 and 3.70 mol% for phospholipid, 0.32 and 0.72 mol% for cholesterol ester, and 0.21 and 0.84 mol% for triacylglycerol.
|Fatty acid||n = 2393||5||10||25||50||75||90||95|
|SAFA||14:0||1.05 (0.55)||0.51 a||0.61||0.78||1.01||1.28||1.57||1.72|
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated; Mean (SD) and percentiles are survey adjusted; a Fatty acids are expressed as a molecular percent (mol%).
|Fatty acid||n = 2416||5||10||25||50||75||90||95|
|SAFA||14:0||0.52 (0.24)||0.30 a||0.33||0.41||0.50||0.60||0.72||0.80|
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated;Mean (SD) and percentiles are survey adjusted;a Fatty acids are expressed as a molecular percent (mol%).
|Fatty acid||n = 2402||5||10||25||50||75||90||95|
|SAFA||14:0||3.62 (2.33)||1.43 a||1.83||2.48||3.36||4.48||5.67||6.53|
|20:0||0.09 (0.25)||0.00||0.00 b||0.05||0.07||0.10||0.15||0.18|
|20:1n-9||0.24 (0.17)||0.00 c||0.14||0.19||0.24||0.29||0.34||0.38|
|22:4n-6||0.12 (0.28)||0.00 d||0.05||0.08||0.10||0.13||0.16||0.20|
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated; Mean (SD) and percentiles are survey adjusted; a Fatty acids are expressed as a molecular percent (mol%); b 9% of participants had values under the detectable limit; c 5% of participants had values under the detectable limit; d 6% of participants had values under the detectable limit.
The results of this study describe the distribution of serum fatty acids, measured as percent of total fatty acids (mol%), in a large, randomly selected sample of adult New Zealanders. The percentiles of fatty acids in serum cholesterol ester, phospholipid and triacylglycerol provide population-based reference ranges against which the fatty acid status of individuals or groups can be compared. For example, with percentile reference ranges it is possible to judge where an individual’s eicosapentaenoic acid level ranks relative to a population-based sample. It is our experience that these reference ranges will be useful to researchers and epidemiologists.
Epidemiological studies which use fatty acids as biomarkers of dietary fat intake or disease risk commonly measure the fatty acid composition of serum or plasma. In this regard, the fatty acid percentiles that we have described for serum are equally applicable to plasma given that Moilanen and Nikkari  found no difference in the fatty acid composition of serum or plasma.
The distribution of serum fatty acids values in a population is influenced by a number of factors but clearly, the most important determinant is the range of dietary fat intakes in the population. These reference fatty acid percentiles are therefore relevant to other countries that have similar fat intakes to New Zealanders. This includes—but is not limited to—populations from Australia, the United Kingdom and the United States; the results of recent national nutrition surveys in these countries indicate that in adults the saturated, monounsaturated and polyunsaturated fat intakes respectively contribute 13%, 12% and 5% of total energy in Australia , 12%, 12% and 6% of total energy in the United Kingdom  and 11%, 13% and 7% of total energy in the United States [9,10].
It is noteworthy that the mean serum fatty acid values from our population based data are similar to the average serum fatty acid composition reported by Hodson et al. . The serum fatty acid values summarised by Hodson et al.  are drawn from studies carried out in a range of different countries, most of which used non-randomly selected convenience samples of participants. This indicates that the range in our population based fatty acid percentiles varies enough so as to be generalizable to a wide range of populations. Although it should be noted that countries which differ markedly from New Zealand in the proportion of saturates and unsaturates in the diet may have slightly different normative distributions for some serum fatty acids. For example, populations with high intakes of fish—such as the Japanese population—would be expected to have a higher proportion of serum n-3 long-chain polyunsaturated fatty acids.
Non-dietary factors—such as sex [11,12,13,14], age [11,15], smoking [16,17,18,19], adiposity , and exercise —can also affect fatty acid composition. In comparison to diet, however, their influence is minor and an individual’s sociodemographic characteristics would not appreciably change the interpretation of their fatty acid status.
One of the main strengths of this study is that the participants were randomly selected from a nationwide sampling frame. There were some small differences in sociodemographic characteristics between the participants who had a fatty acid measurement and the participants who did not, but importantly, there were no differences in dietary fat intakes between these two groups. Thus, the serum fatty acid results are representative of the rest of the survey population. It is worth noting that the NNS97 participants provided non-fasting blood samples and that the precisions of measurement for some of the minor fatty acids were higher than 15%. In the postprandial state, the appearance of chylomicrons in systemic circulation can influence serum fatty acid composition; however, the effect of recent fat ingestion is largely confined to serum triacylglycerol fatty acids and the magnitude of change will depend on the amount of fat in the meal and to what extent the fat differs in composition from usual intake [21,22]. Whilst for an individual there may be discrepancies between the fat content of a recent meal and the usual diet, at a population level it will be similar. Thus, these factors should not have affected the mean fatty acid values but may have broadened the distribution across percentiles. Nevertheless, the results are relevant, particularly given that most large epidemiological studies, such as the European Prospective Investigation into Cancer and Nutrition and the UK Biobank study, also collect non-fasting blood samples for fatty acid analysis [23,24].
The choice of serum lipid class in which to measure fatty acids depends on a large number of factors. For example, is the purpose of the research to assess fat intake or to predict disease risk, to examine saturated fat intake or long chain n-3 polyunsaturated fatty acids? There is no one class of serum lipid that will serve all purposes; however, for particular outcomes some lipid classes may perform better than others. Some of these issues have been addressed elsewhere [1,25].
This study is the first to present reference ranges for the fatty acid composition of the three most common serum lipid classes: cholesterol ester, phospholipid, and triacylglycerol from a large national survey which used population-based sampling techniques. These serum fatty acid percentile reference ranges will be a useful tool for researchers and epidemiologists in guiding the interpretation of the fatty acid status of adult study populations from a wide range of countries.
This work was supported by a research grant from the National Heart Foundation of New Zealand. We acknowledge the New Zealand Ministry of Health which funded the 1997 National Nutrition Survey and the Life in New Zealand group who conducted it. We would also like to thank Christian Thoma, Belinda Hunter and Jody Miller for their technical contribution, and Andrew Gray for his statistical guidance.
- Hodson, L.; Skeaff, C.M.; Fielding, B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid. Res. 2008, 47, 348–380. [Google Scholar]
- Quigley, R.J.; Watts, C. Food Comes First: Methodologies for the National Nutrition Survey of New Zealand; New Zealand Ministry of Health: Wellington, New Zealand, 1997. [Google Scholar]
- Russell, D.G.; Parnell, W.R.; Wilson, N.C.; Faed, J.; Ferguson, E.; Herbison, P. NZ Food: NZ People. Key results of the 1997 National Nutrition Survey; New Zealand Ministry of Health: Wellington, New Zealand, 1999. [Google Scholar]
- Parnell, W.R.; Wilson, N.C.; Russell, D.G. Methodology of the 1997 New Zealand National Nutrition Survey. N. Z. Med. J. 2001, 114, 123–126. [Google Scholar]
- Bligh, E.G.; Dyer, W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37, 911–917. [Google Scholar]
- Moilanen, T.; Nikkari, T. The effect of storage on the fatty acid composition of human serum. Clin. Chim. Acta 1981, 114, 111–116. [Google Scholar]
- McLennan, W.; Podger, A.S. National Nutrition Survey: Nutrient Intakes and Physical Measurements; Australian Bureau of Statistics, Commonwealth of Australia: Canberra, Australia, 1998. [Google Scholar]
- Bates, B.; Lennox, A.; Swan, G. National Diet and Nutrition Survey: Headline Results from Year 1 of the Rolling Programme (2008/2009); Food Standards Agency: London, UK, 2010. [Google Scholar]
- Wright, J.; Wang, C.; Kennedy-Stephenson, J.; Ervin, R. Dietary Intake of Ten Key Nutrients for Public Health, United States: 1999–2000; Advance data from vital and health statistics No. 334; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics: Hyattsville, MD, USA, 2003. [Google Scholar]
- Ervin, R.; Wright, J.; Wang, C.; Kennedy-Stephenson, J. Dietary Intake of Fats and Fatty Acids for the United States Population: 1999–2000; Advance data from vital and health statistics No. 348; Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics: Hyattsville, MD, USA, 2004. [Google Scholar]
- Crowe, F.L.; Skeaff, C.M.; Green, T.J.; Gray, A.R. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br. J. Nutr. 2007, 99, 168–174. [Google Scholar]
- Dewailly, E.; Blanchet, C.; Gingras, S.; Lemieux, S.; Sauvé, L.; Bergeron, J.; Holub, B.J. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am. J. Clin. Nutr. 2001, 74, 603–611. [Google Scholar]
- Dewailly, E.; Blanchet, C.; Lemieux, S.; Sauvé, L.; Gingras, S.; Ayotte, P.; Holub, J.H. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 2001, 74, 464–473. [Google Scholar]
- Tavendale, R.; Lee, A.J.; Smith, W.C.; Tunstall-Pedoe, H. Adipose tissue fatty acids in Scottish men and women: Results from the Scottish Heart Health Study. Atherosclerosis 1992, 94, 161–169. [Google Scholar]
- Asciutti-Moura, L.S.; Guilland, J.C.; Fuchs, F.; Richard, D.; Klepping, J. Fatty acid composition of serum lipids and its relation to diet in an elderly institutionalized population. Am. J. Clin. Nutr. 1988, 48, 980–987. [Google Scholar]
- Pawlosky, R.J.; Hibbeln, J.R.; Salem, N. Compartmental analyses of plasma n-3 essential fatty acids among male and female smokers and nonsmokers. J. Lipid Res. 2007, 48, 935–943. [Google Scholar]
- Simon, J.A.; Fong, J.; Bemert, J.T.; Browner, W.S. Relation of smoking and alcohol consumption to serum fatty acids. Am. J. Epidemiol. 1996, 144, 325–334. [Google Scholar]
- Leng, G.C.; Smith, F.B.; Fowkes, F.G.; Horrobin, D.F.; Ells, K.; Morse-Fisher, N.; Lowe, G.D. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot. Essent. Fatty Acids 1994, 51, 101–108. [Google Scholar]
- Cambien, F.; Warnet, J.M.; Vernier, V.; Ducimetiere, P.; Jacqueson, A.; Flament, C.; Orssaud, G.; Richard, J.L.; Claude, J.R. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factos in middle-aged men. Am. J. Epidemiol. 1988, 127, 75–86. [Google Scholar]
- Helge, J.W.; Wu, B.J.; Willer, M.; Daugaard, J.R.; Storlien, L.H.; Kiens, B. Training affects muscle phospholipid fatty acid composition in humans. J. Appl. Physiol. 2001, 90, 670–677. [Google Scholar]
- Callow, J.; Summers, L.K.M.; Bradshaw, H.; Frayn, K.N. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fat. Am. J. Clin. Nutr. 2002, 76, 345–350. [Google Scholar]
- Cohen, J.C.; Noakes, T.D.; Benade, A.J.S. Serum triglyceride responses to fatty meals: Effects of meal fat content. Am. J. Clin. Nutr. 1998, 47, 825–827. [Google Scholar]
- Crowe, F.L.; Allen, N.E.; Appleby, P.N.; Overvad, K.; Aardestrup, I.V.; Johnsen, N.F.; Tjønneland, A.; Linseisen, J.; Kaaks, R.; Boeing, H.; et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 2008, 88, 1353–1363. [Google Scholar] [PubMed]
- Elliott, P.; Peakman, T.C. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 2008, 37, 234–244. [Google Scholar]
- Arab, L.; Akbar, J. Biomarkers and the measurement of fatty acids. Public Health Nutr. 2002, 5, 865–871. [Google Scholar]
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).